Taeho Jo1,2,3, Kwangsik Nho1,2,3, Shannon L Risacher1,2,3, Andrew J Saykin4,5,6. 1. Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA. 2. Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA. 3. Indiana University Network Science Institute, Bloomington, IN, USA. 4. Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA. asaykin@iupui.edu. 5. Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA. asaykin@iupui.edu. 6. Indiana University Network Science Institute, Bloomington, IN, USA. asaykin@iupui.edu.
Abstract
BACKGROUND: Alzheimer's disease (AD) is the most common type of dementia, typically characterized by memory loss followed by progressive cognitive decline and functional impairment. Many clinical trials of potential therapies for AD have failed, and there is currently no approved disease-modifying treatment. Biomarkers for early detection and mechanistic understanding of disease course are critical for drug development and clinical trials. Amyloid has been the focus of most biomarker research. Here, we developed a deep learning-based framework to identify informative features for AD classification using tau positron emission tomography (PET) scans. RESULTS: The 3D convolutional neural network (CNN)-based classification model of AD from cognitively normal (CN) yielded an average accuracy of 90.8% based on five-fold cross-validation. The LRP model identified the brain regions in tau PET images that contributed most to the AD classification from CN. The top identified regions included the hippocampus, parahippocampus, thalamus, and fusiform. The layer-wise relevance propagation (LRP) results were consistent with those from the voxel-wise analysis in SPM12, showing significant focal AD associated regional tau deposition in the bilateral temporal lobes including the entorhinal cortex. The AD probability scores calculated by the classifier were correlated with brain tau deposition in the medial temporal lobe in MCI participants (r = 0.43 for early MCI and r = 0.49 for late MCI). CONCLUSION: A deep learning framework combining 3D CNN and LRP algorithms can be used with tau PET images to identify informative features for AD classification and may have application for early detection during prodromal stages of AD.
BACKGROUND: Alzheimer's disease (AD) is the most common type of dementia, typically characterized by memory loss followed by progressive cognitive decline and functional impairment. Many clinical trials of potential therapies for AD have failed, and there is currently no approved disease-modifying treatment. Biomarkers for early detection and mechanistic understanding of disease course are critical for drug development and clinical trials. Amyloid has been the focus of most biomarker research. Here, we developed a deep learning-based framework to identify informative features for AD classification using tau positron emission tomography (PET) scans. RESULTS: The 3D convolutional neural network (CNN)-based classification model of AD from cognitively normal (CN) yielded an average accuracy of 90.8% based on five-fold cross-validation. The LRP model identified the brain regions in tau PET images that contributed most to the AD classification from CN. The top identified regions included the hippocampus, parahippocampus, thalamus, and fusiform. The layer-wise relevance propagation (LRP) results were consistent with those from the voxel-wise analysis in SPM12, showing significant focal AD associated regional tau deposition in the bilateral temporal lobes including the entorhinal cortex. The AD probability scores calculated by the classifier were correlated with brain tau deposition in the medial temporal lobe in MCI participants (r = 0.43 for early MCI and r = 0.49 for late MCI). CONCLUSION: A deep learning framework combining 3D CNN and LRP algorithms can be used with tau PET images to identify informative features for AD classification and may have application for early detection during prodromal stages of AD.
Entities:
Keywords:
Alzheimer’s disease; Deep learning; Tau PET
Authors: Geert Litjens; Thijs Kooi; Babak Ehteshami Bejnordi; Arnaud Arindra Adiyoso Setio; Francesco Ciompi; Mohsen Ghafoorian; Jeroen A W M van der Laak; Bram van Ginneken; Clara I Sánchez Journal: Med Image Anal Date: 2017-07-26 Impact factor: 8.545
Authors: Andrew J Saykin; Li Shen; Xiaohui Yao; Sungeun Kim; Kwangsik Nho; Shannon L Risacher; Vijay K Ramanan; Tatiana M Foroud; Kelley M Faber; Nadeem Sarwar; Leanne M Munsie; Xiaolan Hu; Holly D Soares; Steven G Potkin; Paul M Thompson; John S K Kauwe; Rima Kaddurah-Daouk; Robert C Green; Arthur W Toga; Michael W Weiner Journal: Alzheimers Dement Date: 2015-07 Impact factor: 21.566
Authors: Victor L Villemagne; Michelle T Fodero-Tavoletti; Colin L Masters; Christopher C Rowe Journal: Lancet Neurol Date: 2015-01 Impact factor: 44.182
Authors: Michael Schöll; Samuel N Lockhart; Daniel R Schonhaut; James P O'Neil; Mustafa Janabi; Rik Ossenkoppele; Suzanne L Baker; Jacob W Vogel; Jamie Faria; Henry D Schwimmer; Gil D Rabinovici; William J Jagust Journal: Neuron Date: 2016-03-02 Impact factor: 17.173
Authors: Keith A Johnson; Aaron Schultz; Rebecca A Betensky; J Alex Becker; Jorge Sepulcre; Dorene Rentz; Elizabeth Mormino; Jasmeer Chhatwal; Rebecca Amariglio; Kate Papp; Gad Marshall; Mark Albers; Samantha Mauro; Lesley Pepin; Jonathan Alverio; Kelly Judge; Marlie Philiossaint; Timothy Shoup; Daniel Yokell; Bradford Dickerson; Teresa Gomez-Isla; Bradley Hyman; Neil Vasdev; Reisa Sperling Journal: Ann Neurol Date: 2015-12-15 Impact factor: 10.422
Authors: Jonas Richiardi; Andre Altmann; Anna-Clare Milazzo; Catie Chang; M Mallar Chakravarty; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Uli Bromberg; Christian Büchel; Patricia Conrod; Mira Fauth-Bühler; Herta Flor; Vincent Frouin; Jürgen Gallinat; Hugh Garavan; Penny Gowland; Andreas Heinz; Hervé Lemaître; Karl F Mann; Jean-Luc Martinot; Frauke Nees; Tomáš Paus; Zdenka Pausova; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Rainer Spanagel; Andreas Ströhle; Gunter Schumann; Mike Hawrylycz; Jean-Baptiste Poline; Michael D Greicius Journal: Science Date: 2015-06-11 Impact factor: 47.728
Authors: Sebastian Bach; Alexander Binder; Grégoire Montavon; Frederick Klauschen; Klaus-Robert Müller; Wojciech Samek Journal: PLoS One Date: 2015-07-10 Impact factor: 3.240
Authors: Sebastian Palmqvist; Michael Schöll; Olof Strandberg; Niklas Mattsson; Erik Stomrud; Henrik Zetterberg; Kaj Blennow; Susan Landau; William Jagust; Oskar Hansson Journal: Nat Commun Date: 2017-10-31 Impact factor: 14.919
Authors: Shannon L Risacher; Noelia Fandos; Judith Romero; Ian Sherriff; Pedro Pesini; Andrew J Saykin; Liana G Apostolova Journal: Alzheimers Dement (Amst) Date: 2019-07-26
Authors: Tausifa Jan Saleem; Syed Rameem Zahra; Fan Wu; Ahmed Alwakeel; Mohammed Alwakeel; Fathe Jeribi; Mohammad Hijji Journal: J Pers Med Date: 2022-05-18
Authors: James Zou; David Park; Aubrey Johnson; Xinyang Feng; Michelle Pardo; Jeanelle France; Zeljko Tomljanovic; Adam M Brickman; Devangere P Devanand; José A Luchsinger; William C Kreisl; Frank A Provenzano Journal: Alzheimers Dement (Amst) Date: 2021-12-31